BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 28499923)

  • 1. The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior.
    Weinberg F; Reischmann N; Fauth L; Taromi S; Mastroianni J; Köhler M; Halbach S; Becker AC; Deng N; Schmitz T; Uhl FM; Herbener N; Riedel B; Beier F; Swarbrick A; Lassmann S; Dengjel J; Zeiser R; Brummer T
    EBioMedicine; 2017 Jun; 20():79-97. PubMed ID: 28499923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for RIO kinases in the crosshair of cancer research and therapy.
    Ghandadi M; Dobi A; Malhotra SV
    Biochim Biophys Acta Rev Cancer; 2024 May; 1879(3):189100. PubMed ID: 38604268
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated Expression of RIOK1 Is Correlated with Breast Cancer Hormone Receptor Status and Promotes Cancer Progression.
    Huang Z; Li X; Xie T; Gu C; Ni K; Yin Q; Cao X; Zhang C
    Cancer Res Treat; 2020 Oct; 52(4):1067-1083. PubMed ID: 32599985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway.
    Zhang T; Ji D; Wang P; Liang D; Jin L; Shi H; Liu X; Meng Q; Yu R; Gao S
    Cancer Lett; 2018 Feb; 415():151-163. PubMed ID: 29233656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RIOK1 mediates p53 degradation and radioresistance in colorectal cancer through phosphorylation of G3BP2.
    Chen Y; Zhou S; Wan K; Yu L; Zhao C; Deng H; Ou Q; Qin J; Hu J; Hou Z
    Oncogene; 2022 Jun; 41(25):3433-3444. PubMed ID: 35589951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A kinome-wide RNAi screen in Drosophila Glia reveals that the RIO kinases mediate cell proliferation and survival through TORC2-Akt signaling in glioblastoma.
    Read RD; Fenton TR; Gomez GG; Wykosky J; Vandenberg SR; Babic I; Iwanami A; Yang H; Cavenee WK; Mischel PS; Furnari FB; Thomas JB
    PLoS Genet; 2013; 9(2):e1003253. PubMed ID: 23459592
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting posttranslational modifications of RIOK1 inhibits the progression of colorectal and gastric cancers.
    Hong X; Huang H; Qiu X; Ding Z; Feng X; Zhu Y; Zhuo H; Hou J; Zhao J; Cai W; Sha R; Hong X; Li Y; Song H; Zhang Z
    Elife; 2018 Jan; 7():. PubMed ID: 29384474
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Rio1 protein kinases/ATPases: conserved regulators of growth, division, and genomic stability.
    Berto G; Ferreira-Cerca S; De Wulf P
    Curr Genet; 2019 Apr; 65(2):457-466. PubMed ID: 30515528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Oncogenic Protein Kinase/ATPase RIOK1 Is Up-Regulated via the c-myc/E2F Transcription Factor Axis in Prostate Cancer.
    Handle F; Puhr M; Gruber M; Andolfi C; Schäfer G; Klocker H; Haybaeck J; De Wulf P; Culig Z
    Am J Pathol; 2023 Sep; 193(9):1284-1297. PubMed ID: 37301535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TIPE3 protein promotes breast cancer metastasis through activating AKT and NF-κB signaling pathways.
    Lian K; Ma C; Hao C; Li Y; Zhang N; Chen YH; Liu S
    Oncotarget; 2017 Jul; 8(30):48889-48904. PubMed ID: 28388580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
    Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
    Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of MET by ionizing radiation and its role in radioresistance and invasive growth of cancer.
    De Bacco F; Luraghi P; Medico E; Reato G; Girolami F; Perera T; Gabriele P; Comoglio PM; Boccaccio C
    J Natl Cancer Inst; 2011 Apr; 103(8):645-61. PubMed ID: 21464397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The inflammatory cytokine TNFα cooperates with Ras in elevating metastasis and turns WT-Ras to a tumor-promoting entity in MCF-7 cells.
    Leibovich-Rivkin T; Liubomirski Y; Meshel T; Abashidze A; Brisker D; Solomon H; Rotter V; Weil M; Ben-Baruch A
    BMC Cancer; 2014 Mar; 14():158. PubMed ID: 24598028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Src Promotes Metastasis of Human Non-Small Cell Lung Cancer Cells through Fn14-Mediated NF-κB Signaling.
    Wang W; Liu F; Wang C; Wang C; Tang Y; Jiang Z
    Med Sci Monit; 2018 Mar; 24():1282-1294. PubMed ID: 29500337
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate.
    Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J
    Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysyl oxidase inhibits ras-mediated transformation by preventing activation of NF-kappa B.
    Jeay S; Pianetti S; Kagan HM; Sonenshein GE
    Mol Cell Biol; 2003 Apr; 23(7):2251-63. PubMed ID: 12640111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-Raf deficiency impairs tumor initiation and progression in a murine breast cancer model.
    Köhler M; Ehrenfeld S; Halbach S; Lauinger M; Burk U; Reischmann N; Cheng S; Spohr C; Uhl FM; Köhler N; Ringwald K; Braun S; Peters C; Zeiser R; Reinheckel T; Brummer T
    Oncogene; 2019 Feb; 38(8):1324-1339. PubMed ID: 30659267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Downstream effectors of oncogenic ras in multiple myeloma cells.
    Hu L; Shi Y; Hsu JH; Gera J; Van Ness B; Lichtenstein A
    Blood; 2003 Apr; 101(8):3126-35. PubMed ID: 12515720
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TMEM43/LUMA is a key signaling component mediating EGFR-induced NF-κB activation and tumor progression.
    Jiang C; Zhu Y; Zhou Z; Gumin J; Bengtsson L; Wu W; Songyang Z; Lang FF; Lin X
    Oncogene; 2017 May; 36(20):2813-2823. PubMed ID: 27991920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IL6 Blockade Reprograms the Lung Tumor Microenvironment to Limit the Development and Progression of K-ras-Mutant Lung Cancer.
    Caetano MS; Zhang H; Cumpian AM; Gong L; Unver N; Ostrin EJ; Daliri S; Chang SH; Ochoa CE; Hanash S; Behrens C; Wistuba II; Sternberg C; Kadara H; Ferreira CG; Watowich SS; Moghaddam SJ
    Cancer Res; 2016 Jun; 76(11):3189-99. PubMed ID: 27197187
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.